Back to today’s briefing

Story perspectives

Trump Administration Weighs Hemmati for FDA Biologics Role

4/14/2026

48 8 Full Breakdown

Summary

Story summary

U.S. President Donald Trump’s administration is considering appointing Houman Hemmati to lead the FDA's Center for Biologics Evaluation and Research.
Hemmati is an ophthalmologist and frequent Fox News guest.
No decision has been finalized.
Hemmati's potential appointment follows the departure of Vinay Prasad, the current director, who has criticized U.S. drug and vaccine policies.

1 of 1

Story summary

U.S. President Donald Trump’s administration is considering appointing Houman Hemmati to lead the FDA's Center for Biologics Evaluation and Research.
Hemmati is an ophthalmologist and frequent Fox News guest.
No decision has been finalized.
Hemmati's potential appointment follows the departure of Vinay Prasad, the current director, who has criticized U.S. drug and vaccine policies.